David Shreiber was named Vice Provost for Academic Affairs at Rutgers University–New Brunswick. In the Vice Provost role, Dr. Shreiber will provide leadership for high-quality academic programming, teaching and learning, assessment, and program … Read More
A two-year, $50,000 pilot grant has been awarded by the New Jersey Commission on Cancer Research to Professor David Shreiber and Dr. Kelly Kyker-Snowman to develop models to study epithelial-to-mesenchymal transitions associated with ovarian … Read More
The REU Site in Cellular Bioengineering, directed by Professor Shreiber, was renewed for three years with a $428,240 grant from the National Science Foundation. The next 3-year cycle of the … Read More
Professor Shreiber has been awarded an $8,000 International Collaborative Research Grant from Rutgers Global to support a collaboration with Professor Fei Xu from Jiangnan University in China. The funds will … Read More
The research described in the Biointerphases publication was featured on the cover of the journal issue and has been highlighted by a number of news sources: Rutgers Today 3DMedNet … Read More
Rutgers engineering faculty Jeffrey Zahn and David Shreiber (BME) and Hao Lin and Jerry Shan (MAE) have partnered with a life science company to model and develop transdermal gene and … Read More
Timo Roehrs defended his MS thesis, entitled “Encapsulation of mesenchymal stem cells as a potential treatment for stroke, modeled as an oxygen glucose deprived system.” Congratulations, Timo!
Advanced Biomatrix began sale of collagen methacrylamide under the trade-name Photocol. Photocol is a photo-crosslinkable collagen-based biomaterial.
David Shreiber has been promoted to the rank of Professor in the Department of Biomedical Engineering.
David Shreiber was recognized by Turnitin for his achievements in developing tools and policies to limit plagirism in graduate studies. You can listen to Dr. Shreiber describe his efforts here.